What is the target AUC for vancomycin?

The 2020 vancomycin consensus guideline targets a 24-hour AUC to MIC ratio of 400 to 600, assuming an MIC of 1 mg/L for MRSA. An AUC below 400 risks treatment failure; above 600 the risk of kidney injury rises. Bayesian software using measured levels is preferred for individual patients; this calculator gives the evidence-based starting regimen.

What is the vancomycin loading dose?

For serious MRSA infections, 20 to 25 mg/kg of actual body weight as a single loading dose (capped at 3,000 mg), infused at no more than 1 g per hour to avoid red man syndrome. A loading dose is not needed for mild infections or when renal function is unstable.

How is vancomycin clearance estimated?

This calculator uses the Matzke method: elimination rate constant ke = 0.00083 x creatinine clearance + 0.0044 per hour, volume of distribution 0.7 L/kg, and clearance = ke x Vd. Because vancomycin is cleared almost entirely by the kidneys, clearance tracks creatinine clearance closely.

Why did guidelines move from troughs to AUC monitoring?

Trough-only monitoring (15-20 mcg/mL) was a surrogate for the AUC, but targeting high troughs pushed many patients above an AUC of 600 and increased kidney injury without better cure rates. AUC-guided dosing achieves the same efficacy target with lower, safer exposures.

What vancomycin interval should be used in kidney failure?

The interval stretches as creatinine clearance falls: roughly every 8 hours at normal clearance, every 12 hours at 50-89 mL/min, every 24 hours at 30-49, and every 24-48 hours below 30, always confirmed with levels.

When should vancomycin levels be drawn?

For AUC-guided monitoring, draw one or two levels after the third or fourth dose at steady state (a trough 30 minutes before the next dose, and optionally a peak 1-2 hours after the infusion ends). Feed them into Bayesian dosing software to compute the true AUC and adjust the regimen.

Vancomycin AUC Dosing Calculator

Size vancomycin loading and maintenance doses for an AUC24 of 400 to 600 using the Matzke pharmacokinetic method, per the 2020 consensus guideline. Enter the patient's details below; the calculator estimates clearance from creatinine clearance and proposes a starting regimen.

Vancomycin dosing tool

Age (years) Sex Actual body weight (kg) Height (cm) Serum creatinine (mg/dL) Target AUC24

Key definitions

AUC24: The area under the vancomycin concentration-time curve over 24 hours, in mg.h/L. It summarises total drug exposure and is the pharmacodynamic target linked to both efficacy and kidney injury.
AUC/MIC: The AUC24 divided by the minimum inhibitory concentration of the infecting organism. The guideline target of 400 to 600 assumes an MIC of 1 mg/L; if the true MIC is higher, the same AUC buys less effect.
Matzke method: A population pharmacokinetic method for vancomycin: elimination rate constant ke = 0.00083 x creatinine clearance + 0.0044 per hour, volume of distribution 0.7 L/kg, clearance = ke x Vd.
Loading dose: A single larger first dose (20 to 25 mg/kg) that fills the volume of distribution quickly so therapeutic concentrations are reached with the first dose rather than after several half-lives.
Red man syndrome: Histamine-mediated flushing, itching and hypotension caused by rapid vancomycin infusion; prevented by limiting the infusion rate to 1 g per hour (at least 60 minutes per gram).

Why AUC replaced trough monitoring

For two decades, vancomycin dosing aimed at a trough of 15 to 20 mcg/mL, on the theory that the trough was a convenient stand-in for total exposure. The problem, recognised in the 2020 consensus guideline from ASHP, IDSA, PIDS and SIDP, was that the stand-in was a poor one. Pushing troughs into the 15 to 20 range drove a large fraction of patients above an AUC of 600, where the risk of acute kidney injury climbs steeply, without any demonstrable improvement in cure rates. The trough was measuring the wrong thing at the wrong time: two patients with the same trough can have very different AUCs depending on their clearance and half-life.

The AUC itself is what correlates with bacterial killing for vancomycin, and the target range of 400 to 600 (as AUC/MIC, assuming MIC 1 mg/L) captures the exposure associated with efficacy in serious MRSA infections while staying below the nephrotoxicity threshold. AUC-guided dosing typically achieves the target with lower total daily doses than trough-guided dosing did, which is the whole point: same efficacy, less kidney injury. This calculator sizes the starting regimen for a chosen AUC within that range. It does not replace measured levels. The guideline's preferred approach for the individual patient is Bayesian software fed with one or two measured concentrations, which estimates the patient's true clearance far better than any population equation.

How the Matzke method works

The Matzke method is a simple population pharmacokinetic model built on one observation: vancomycin is cleared almost entirely by glomerular filtration, so its elimination rate tracks creatinine clearance in a straight line. The equation ke = 0.00083 x CrCl + 0.0044 per hour was derived from measured vancomycin pharmacokinetics across a range of renal function, and it remains the most widely used bedside estimator. Volume of distribution is taken as 0.7 L/kg of actual body weight, and clearance follows as ke x Vd in litres per hour.

From clearance, the maintenance dose is arithmetic: daily dose = target AUC x clearance. If the target is 500 and clearance is 4 L/h, the patient needs 2,000 mg per day, divided into the interval dictated by kidney function. The calculator rounds each dose to the nearest 250 mg because vancomycin comes in 500 mg and 1 g vials and odd doses create preparation errors. It then reports the predicted AUC of the rounded regimen so you can confirm it still sits inside 400 to 600 before prescribing.

Body weight needs care. In obesity, creatinine clearance estimated with actual body weight overstates true glomerular filtration, while ideal body weight understates drug clearance for a drug that distributes partly into excess tissue. The calculator follows the common compromise: if actual weight exceeds 120% of ideal (Devine) body weight, it uses adjusted body weight (ideal + 0.4 x excess) for the creatinine clearance estimate, while volume of distribution still uses actual weight. It tells you when it has done this.

Dosing intervals by kidney function

The interval is chosen so that concentrations fall adequately between doses without leaving long subtherapeutic gaps. At a creatinine clearance of 90 mL/min or above, every 8 hours is typical; from 50 to 89, every 12 hours; from 30 to 49, every 24 hours; below 30, every 24 to 48 hours with measured levels guiding. These are starting points, not rules: the half-life the calculator reports tells you the same story in numbers. A half-life of 9 hours suits twice-daily dosing; a half-life of 25 hours does not.

Worked example: a 65-year-old man, 80 kg, 178 cm, serum creatinine 1.0 mg/dL. Ideal body weight is 73.3 kg, so actual weight is used. Creatinine clearance is 83.3 mL/min, ke 0.0736/h, Vd 56 L, clearance 4.12 L/h, half-life 9.4 hours. For a target AUC of 500, the daily need is 2,060 mg; divided into two doses and rounded, that is 1,000 mg every 12 hours, with a predicted AUC of 485, comfortably inside the target. The loading dose for serious infection is 1,600 to 2,000 mg once, infused over at least 2 hours.

Second example: an 80-year-old woman, 60 kg, 160 cm, creatinine 1.5 mg/dL. Creatinine clearance is 28.3 mL/min and the half-life stretches to 24.8 hours. The calculator proposes 500 mg every 24 hours, predicting an AUC of 426, and flags the low clearance for level confirmation. Below a clearance of 20, it declines to propose a routine interval and directs you to Bayesian software with measured levels, which is the honest answer when the pharmacokinetics are that slow.

Monitoring and dose adjustment

Draw the first levels at steady state, after the third or fourth maintenance dose: a trough 30 minutes before the next dose, and optionally a peak 1 to 2 hours after the infusion ends. A single trough plus Bayesian software is enough to estimate the true AUC; two levels improve the estimate. Recheck whenever renal function changes, when nephrotoxins are added, or when the clinical response is poor. Nephrotoxicity risk rises with AUC above 600, with concurrent aminoglycosides, loop diuretics, contrast or hypotension, and with therapy beyond a few days, so the kidney function trend matters as much as any single level.

When the measured AUC comes back outside 400 to 600, adjust proportionally: new daily dose = old daily dose x (target AUC / measured AUC). This linear adjustment works because vancomycin follows first-order kinetics in the therapeutic range. Then recheck. Vancomycin dosing is iterative by nature; the calculator gets you a defensible starting regimen, and levels get you the right one.

Limitations and pitfalls

The Matzke equation is a population average fitted to stable adults, and it degrades exactly where you need it most: acute kidney injury with a rapidly changing creatinine, the frail elderly with little muscle mass (whose creatinine flatters their true filtration), severe obesity, pregnancy, burns and critical illness with augmented renal clearance. In augmented renal clearance, common in young trauma and neurocritical care patients, true vancomycin clearance can far exceed the estimate and standard regimens underdose badly; levels are essential.

The calculator assumes an MIC of 1 mg/L. If the laboratory reports an MIC of 2, an AUC of 500 gives an AUC/MIC of only 250, which is inadequate, and no safe dose achieves 400 to 600; that is a signal to change therapy, not to push the dose. It also assumes the creatinine is at steady state: a creatinine drawn during resuscitation or after contrast does not reflect the clearance the patient will have tomorrow. Finally, the loading dose cap of 3,000 mg and the infusion rate limit are safety features, not suggestions; red man syndrome from rapid infusion is entirely preventable.

Key takeaways

Target an AUC24/MIC of 400 to 600 for serious MRSA infections, not a trough of 15 to 20.
Give a 20 to 25 mg/kg loading dose (max 3,000 mg) for serious infections, infused at no more than 1 g per hour.
Size maintenance as target AUC x clearance (Matzke: ke = 0.00083 x CrCl + 0.0044, Vd 0.7 L/kg), rounded to practical doses.
Stretch the interval as creatinine clearance falls: q8h, q12h, q24h, then levels-guided.
Confirm with measured levels and Bayesian software; adjust proportionally and recheck.

Frequently asked questions

What is the target AUC for vancomycin?: The 2020 consensus guideline targets an AUC24/MIC of 400 to 600 assuming an MIC of 1 mg/L. Below 400 risks treatment failure; above 600 the risk of kidney injury rises steeply.
What is the vancomycin loading dose?: 20 to 25 mg/kg of actual body weight as a single dose (capped at 3,000 mg) for serious MRSA infections, infused at no more than 1 g per hour. Omit it for mild infections or unstable renal function.
How is vancomycin clearance estimated?: By the Matzke method: ke = 0.00083 x creatinine clearance + 0.0044 per hour, Vd 0.7 L/kg, clearance = ke x Vd. Vancomycin is cleared almost entirely by the kidneys, so clearance tracks creatinine clearance closely.
Why did guidelines move from troughs to AUC?: Trough targeting pushed many patients above an AUC of 600, increasing kidney injury without better cure rates. AUC-guided dosing hits the same efficacy target with lower, safer total exposure.
What interval should be used in kidney failure?: Roughly q8h at normal clearance, q12h at 50-89 mL/min, q24h at 30-49, and q24-48h below 30, always confirmed with levels. Below 20 mL/min, use Bayesian software with measured levels.
When should vancomycin levels be drawn?: At steady state after the third or fourth dose: a trough 30 minutes before the next dose, optionally plus a peak 1-2 hours after the infusion. Recheck after any renal function change.
What if the MRSA MIC is 2 mg/L?: Then an AUC of 400-600 gives an AUC/MIC of only 200-300, which is inadequate, and no safe dose reaches the target. Consider alternative therapy rather than pushing the dose into nephrotoxic range.
Does obesity change the dose?: Yes. The calculator uses adjusted body weight for creatinine clearance when actual weight exceeds 120% of ideal body weight, while volume of distribution uses actual weight. Confirm with levels, as obesity pharmacokinetics vary.

Gentamicin Dosing Calculator - extended-interval, traditional and synergy regimens.
Aminoglycoside Pharmacokinetic Dosing Calculator - Sawchuk-Zaske individualisation from measured levels.
Digoxin Dosing Calculator - another narrow-index drug dosed by kidney function.
Nephrology calculators - creatinine clearance and kidney function tools.

References

Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious MRSA infections: a revised consensus guideline. Am J Health Syst Pharm. 2020;77(11):835-864. - IDSA guideline resource
Matzke GR, McGory RW, Halstenson CE, Keane WF. Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother. 1984;25(4):433-437.

Medical disclaimer

This calculator is an educational tool for clinicians, students and informed readers. It does not provide medical advice. Vancomycin dosing for serious infections should be confirmed with therapeutic drug monitoring and local pharmacy or antimicrobial stewardship guidance. Never start, stop or change a prescribed medicine on the basis of a calculator result alone; if you are unwell, seek professional care promptly.